← Back to Clinical Trials
Recruiting NCT06939478

AI Powered Mapping Technology for Identifying Arrhythmias

Trial Parameters

Condition Arrhythmias, Cardiac
Sponsor Heart Rhythm Clinical and Research Solutions, LLC
Study Type OBSERVATIONAL
Phase N/A
Enrollment 110
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2025-08-27
Completion 2025-12
Interventions
Arrhythmia Mapping

Brief Summary

Exploratory, hypothesis-generating study evaluating the impact of vMap on procedural efficiency, acute success, and work flow optimization.

Eligibility Criteria

Retrospective Arm: Inclusion Criteria: 1. Patients who had a standard of care cardiac ablation (de novo or repeat) where the vMap equipment was used. 2. The patient can provide written informed consent, if applicable. 3. The patient is greater than or equal to 18 years old Prospective Arm: Inclusion Criteria: 1. Patients who had a standard of care cardiac ablation (de novo or repeat) where the vMap equipment was used. 2. The patient can provide written informed consent, if applicable. 3. The patient is greater than or equal to 18 years old Exclusion Criteria: Participants who meet any one of the following criteria will be a screen failure and excluded from participation: 1. Non-inducible arrhythmia (unless pre-mapped via vMap prior to the procedure). 2. Patients in whom no ablation was performed using the vMap equipment. 3. Inability to obtain 12-lead ECG of sufficient quality for vMap analysis. 4. In the opinion of the Investigator, the participant is not suitable and has a contraindi

Related Trials